Journal issues > Issue Special, March 2024 > Bladder cancer – how to optimise shared decision-making

Bladder cancer – how to optimise shared decision-making

During the bladder cancer session at BMUC 2024; Prof. Ananya Choudhury (The University of Manchester, Manchester) underscored the necessity of reevaluating radiotherapy as a treatment for localised non-muscle invasive bladder cancer (NMIBC), underscoring its efficacy and safety also in elderly patients. Prof. Evanguelos Xylinas (Hôpital Bichat-Claude Bernard – APHP Nord, Paris) focused on emerging therapies for high-risk NMIBC patients unresponsive to Bacillus Calmette-Guérin treatment, such as intravesical gene therapy or immunotherapy. Finally, Prof. Sylvie Rottey (University Hospital Ghent, Ghent) discussed the pivotal Check-Mate-901 and EV-302 trials, which have transformed the first-line treatment of metastatic urothelial carcinoma.

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top